IAG is Leading AI powered Drug Development and Precision Medicine

IAG's CEO, Dr. Kubassova Guest Starring on the RP HealthCast Podcast

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions - Vatansever - 2021 - Medicinal Research Reviews - Wiley Online Library

IAG is Leading AI powered Drug Development and Precision Medicine.

AI is dreaming up drugs that no one has ever seen. Now we've got to see if they work.

The cycle showing the involvement of AI learning in drug design

The Role of Central Imaging in Successful Oncology Clinical Trials

IAG are attending European Crohn's and Colitis Organisation Congress 2023

AI-based language models powering drug discovery and development - ScienceDirect

AI Drug Discovery: Key Trends and Developments in Pharma Industry

Artificial intelligence for precision medicine in neurodevelopmental disorders

BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market

WPD Pharmaceuticals, Inc. & IAG, Image Analysis Group will Deploy AI and Quantitative Imaging to Advance New GBM Treatment

Full article: Can artificial intelligence accelerate preclinical drug discovery and precision medicine?

3 AI trends in drug discovery that stood out in 2022